Physician profile
Robert Dylan Thomas
NPI 1699733774
$4,966.04
in general payments reported to CMS, 2019-2025
22 companies · $2,962 in 2025
The $2,962 reported for 2025 was more than what 93% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2021: $107 · 2022: $559 · 2023: $408 · 2024: $624 · 2025: $2,962.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,055 · Travel and Lodging: $1,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,054.95 |
| Travel and Lodging | $1,940.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,361.92 | 2024-2025 | Straightshot, Stealthstation S8 Platform, Propel |
| Stryker Corporation | $542.93 | 2021-2022 | |
| Genzyme Corporation | $238.30 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $225.69 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $196.70 | 2022-2025 | Dupixent |
| Inspire Medical Systems, INC. | $196.44 | 2019 | |
| Organogenesis INC. | $176.41 | 2024-2025 | Novachor, Affinity |
| Integra Lifesciences Corporation | $172.50 | 2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Itamar Medical INC | $139.18 | 2022-2023 | Watchpatone |
| Smith+Nephew, INC. | $138.14 | 2025 | Tula, Halo |
| Acclarent, INC | $132.35 | 2022-2023 | Acclarent Aera, Trudi Nav Cable |
| Zoll Respicardia, INC. | $118.60 | 2024 | Remede System |
| Preceptis Medical, INC. | $95.13 | 2025 | |
| Phathom Pharmaceuticals, INC. | $38.18 | 2024-2025 | Voquezna |
| Axsome Therapeutics, INC. | $37.47 | 2023 | Sunosi |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $31.68 | 2023-2025 | Lumryz |
| Glaxosmithkline, LLC. | $29.62 | 2023 | Nucala |
| Arbor Pharmaceuticals, INC. | $24.53 | 2019 | |
| Optinose US, INC. | $20.04 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $19.00 | 2025 | Tezspire |
| Alk-Abello, INC | $17.40 | 2023 | Timothy, Standardized, Standardized Mite D. Farinae, Histamine Positive |
| Aerin Medical INC. | $13.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.